Prudential Financial Inc. bought a new stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) in the fourth quarter ...

Lawyers inside and outside the US Securities and Exchange Commission (SEC) have speculated that the agency’s new leadership will take a ...

Soleno Therapeutics is nearing FDA approval for its lead drug, DCCR, targeting Prader-Willi Syndrome, a rare genetic ...

Some of the best stocks on the market once traded at less than $5 a share. Look at Advanced Micro Devices. Back in 2016, the ...

In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ ... Investors looking for promising yet lower-priced stocks, particularly those trading under $20, may find ...

We recently published a list of 12 Best Nasdaq Stocks Under $20 to Buy Now. In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands against other best ...

There has been a lot of insider trading at Tesla lately, and by trading, we mean selling – cause no insider is ever buying at Tesla. We recently reported on Kimball Musk, Elon’s brother ...

George Demos, former vice president of drug safety and pharmacovigilance at Acadia Pharmaceuticals Inc., sold off more than 60,000 of his nearly 65,000 total option shares one day before the ...

George Demos, former vice president of drug safety and pharmacovigilance at Acadia Pharmaceuticals Inc., is the latest biopharma executive to plead guilty to insider trading charges. BioWorld ...

March 9, 2025 – SAN DIEGO, CA – George Demos, then-vice president at San Diego-based Acadia Pharmaceuticals ... Demos was subject to an insider trading policy that prohibited trading in ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted ... guilty today to a federal securities fraud count for insider trading. George Demos, 64, formerly of Acadia Pharmaceuticals ...